Browsing by Yonsei Author : Ahn, Sung Gwe

eperson profile image
Name:
Ahn, Sung Gwe [안성귀]
orcid http://orcid.org/0000-0002-8778-9686
Department :
College of Medicine (의과대학) - Dept. of Surgery (외과학교실)
Scopus ID :
Scopus (36336893800)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 123

This table browses all dspace content
Issue DateTitleJournal Title
2024Stromal tumor-infiltrating lymphocytes and pathologic response to neoadjuvant chemotherapy with the addition of platinum and pembrolizumab in TNBC: a single-center real-world study BREAST CANCER RESEARCH
2024Clinical Relevance of <i>TP53</i> Mutation and Its Characteristics in Breast Cancer with Long-Term Follow-Up Date CANCERS
2024Age and Late Recurrence in Young Patients With ER-Positive, <i>ERBB2</i>-Negative Breast Cancer JAMA NETWORK OPEN
2024Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 h+HER2-breast cancer: a retrospective analysis BREAST CANCER RESEARCH
2024Immune environment of high-TIL breast cancer: triple negative and hormone receptor positive HER2 negative NPJ BREAST CANCER
2024Dural Metastasis in Breast Cancer: MRI-Based Morphological Subtypes and Their Clinical Implications CANCER RESEARCH AND TREATMENT
2024De novo versus recurrent metastatic breast cancer affects the extent of brain metastasesJOURNAL OF NEURO-ONCOLOGY
2024Micrometastases in axillary lymph nodes in breast cancer, post-neoadjuvant systemic therapy BREAST CANCER RESEARCH
2024Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification SCIENTIFIC REPORTS
2024Selective Avoidance of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Human Epidermal Growth Factor 2-Positive/Triple-Negative Breast Cancer Patients With Excellent ResponseJOURNAL OF BREAST CANCER
2024Selective omission of sentinel lymph node biopsy in mastectomy for ductal carcinoma in situ: identifying eligible candidates BREAST CANCER RESEARCH
2024Outcomes of sentinel node biopsy according to MRI response in an association with the subtypes in cN1-3 breast cancer after neoadjuvant systemic therapy, multicenter cohort study BREAST CANCER RESEARCH
2024Tumor-Infiltrating Lymphocyte Level Consistently Correlates with Lower Stiffness Measured by Shear-Wave Elastography: Subtype-Specific Analysis of Its Implication in Breast Cancer CANCERS
2024Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy YONSEI MEDICAL JOURNAL
2024Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority Trial JOURNAL OF BREAST CANCER
2024Predictive Markers of Treatment Response to Neoadjuvant Systemic Therapy with Dual HER2-Blockade CANCERS
2024Prediction of a Multi-Gene Assay (Oncotype DX and Mammaprint) Recurrence Risk Group Using Machine Learning in Estrogen Receptor-Positive, HER2-Negative Breast Cancer-The BRAIN Study CANCERS
2024Elasticity Values as a Predictive Modality for Response to Neoadjuvant Chemotherapy in Breast Cancer CANCERS
2024BRCA1 mutation promotes sprouting angiogenesis in inflammatory cancer-associated fibroblast of triple-negative breast cancer CELL DEATH DISCOVERY
2023YAP1 Expression in HR+HER2- Breast Cancer: 21-Gene Recurrence Score Analysis and Public Dataset Validation CANCERS
2023Prognostic impact of radiotherapy-induced-lymphopenia in patients treated with breast-conservative surgery SCIENTIFIC REPORTS
2023Investigation of Factors Affecting Adherence to Adjuvant Hormone Therapy in Early-Stage Breast Cancer Patients: A Comprehensive Systematic Review JOURNAL OF BREAST CANCER
2023Ki-67, 21-Gene Recurrence Score, Endocrine Resistance, and Survival in Patients With Breast Cancer JAMA NETWORK OPEN
2023Comparison of Programmed Cell Death Ligand 1 Status between Core Needle Biopsy and Surgical Specimens of Triple-Negative Breast Cancer YONSEI MEDICAL JOURNAL
2023Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)BREAST CANCER
2023Radiation dose-event relationship after intraoperative radiotherapy as a boost in patients with breast cancer FRONTIERS IN ONCOLOGY
2023Optimal treatment strategy for hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer patients with 1-2 suspicious axillary lymph node metastases on breast magnetic resonance imaging: upfront surgery vs. neoadjuvant chemotherapy FRONTIERS IN ONCOLOGY
2023Resolution of Nonmass Enhancement Extension to the Nipple at Breast MRI after Neoadjuvant Chemotherapy: Pathologic Response and Feasibility for Nipple-sparing MastectomyRADIOLOGY
2023Complications Including Capsular Contracture in Direct-to-Implant Breast Reconstruction With Textured Anatomical Versus Smooth Round Implants: A Single Center Retrospective Analysis JOURNAL OF BREAST CANCER
2023Knowledge, attitudes, and behaviors toward fertility preservation in patients with breast cancer: A cross-sectional survey of physicians FRONTIERS IN ONCOLOGY
2023Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP CANCER MEDICINE
2022Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Early Standardized Uptake Value Reduction in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy JOURNAL OF BREAST CANCER
202218F-FDG uptake of visceral adipose tissue on preoperative PET/CT as a predictive marker for breast cancer recurrence SCIENTIFIC REPORTS
2022Association of Body Mass Index With 21-Gene Recurrence Score Among Women With Estrogen Receptor-Positive, ERBB2-Negative Breast Cancer JAMA NETWORK OPEN
2022Correlation of Yes-Associated Protein 1 with Stroma Type and Tumor Stiffness in Hormone-Receptor Positive Breast Cancer CANCERS
2022Residual Tumor Patterns of Breast Cancer on MRI after Neo-Adjuvant Chemotherapy: Impact on Clinicopathologic Factors and Prognosis DIAGNOSTICS
2022CD39+ tissue-resident memory CD8+ T cells with a clonal overlap across compartments mediate antitumor immunity in breast cancerSCIENCE IMMUNOLOGY
2022Effects of Single Nucleotide Polymorphisms and Mediterranean Diet in Overweight or Obese Postmenopausal Women With Breast Cancer Receiving Adjuvant Hormone Therapy: A Pilot Randomized Controlled Trial FRONTIERS IN NUTRITION
2022RT-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with breast cancer indicate poor prognosisBREAST CANCER RESEARCH AND TREATMENT
2022SP142 PD-L1 Assays in Multiple Samples from the Same Patients with Early or Advanced Triple-Negative Breast Cancer CANCERS
2022Primary endocrine resistance of ER+ breast cancer with ESR1 mutations interrogated by droplet digital PCR NPJ BREAST CANCER
2022Survival Outcomes of Patients With Breast Cancer Diagnosed Using Vacuum-Assisted Biopsy: A Nationwide Study From the Korean Breast Cancer Society JOURNAL OF BREAST CANCER
2022Association between TP53 mutation and high 21-gene recurrence score in estrogen receptor-positive/HER2-negative breast cancer NPJ BREAST CANCER
2022Added value of abbreviated breast magnetic resonance imaging for assessing suspicious microcalcification on screening mammography-a prospective studyEUROPEAN RADIOLOGY
2021The Impact of Post-Mastectomy Radiotherapy on Survival Outcomes in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy CANCERS
2021Relationship of the standard uptake value of 18 F-FDG-PET-CT with tumor-infiltrating lymphocytes in breast tumors measuring ≥ 1 cm SCIENTIFIC REPORTS
2021Diagnostic Accuracy of Nonmass Enhancement at Breast MRI in Predicting Tumor Involvement of the Nipple: A Prospective Study in a Single InstitutionRADIOLOGY
2021PD-L1 expression evaluated by 22C3 antibody is a better prognostic marker than SP142/SP263 antibodies in breast cancer patients after resection SCIENTIFIC REPORTS
2021Axillary response according to neoadjuvant single or dual human epidermal growth factor receptor 2 (HER2) blockade in clinically node-positive, HER2-positive breast cancer INTERNATIONAL JOURNAL OF CANCER
2021Metastasis Risk Assessment Using BAG2 Expression by Cancer-Associated Fibroblast and Tumor Cells in Patients with Breast Cancer CANCERS

Browse

Links